chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Feeling abnormal, Hypersensitivity, Pain in extremity, Peripheral swelling
Clinical narrative: arm was very sore; arm was swollen; allergic reaction; could hardly get out of bed because her back pain was so bad; felt really bad; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (could hardly get out of bed because her back pain was so bad), FEELING ABNORMAL (felt really bad), PAIN IN EXTREMITY (arm was very sore), PERIPHERAL SWELLING (arm was swollen) and HYPERSENSITIVITY (allergic reaction) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced BACK PAIN (could hardly get out of bed because her back pain was so bad) and FEELING ABNORMAL (felt really bad). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm was very sore), PERIPHERAL SWELLING (arm was swollen) and HYPERSENSITIVITY (allergic reaction). In February 2021, BACK PAIN (could hardly get out of bed because her back pain was so bad) and FEELING ABNORMAL (felt really bad) had resolved. At the time of the report, PAIN IN EXTREMITY (arm was very sore) and PERIPHERAL SWELLING (arm was swollen) had resolved and HYPERSENSITIVITY (allergic reaction) outcome was unknown.            No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No specific follow-up information recorded.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Myalgia, Tenderness, Vaccination site erythema
Clinical narrative: 6 inch patch of rash over the top of my left shoulder and down across the armpit with itching; 6 inch patch of rash over the top of my left shoulder and down across the armpit; body aches; flash headache; injection site swelled up and got very hot; injection site swelled up; a band of red 2 inches below the injection site; Redness; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), TENDERNESS (tenderness), VACCINATION SITE WARMTH (injection site swelled up and got very hot), VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching) and VACCINATION SITE SWELLING (injection site swelled up) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included WELLNESS FORMULA for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced ERYTHEMA (Redness) and TENDERNESS (tenderness). On 17-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site swelled up and got very hot), VACCINATION SITE SWELLING (injection site swelled up) and VACCINATION SITE ERYTHEMA (a band of red 2 inches below the injection site). On 26-Feb-2021, the patient experienced HEADACHE (flash headache). On 27-Feb-2021, the patient experienced MYALGIA (body aches). On 04-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching) and VACCINATION SITE RASH (6 inch patch of rash over the top of my left shoulder and down across the armpit). On 21-Feb-2021, VACCINATION SITE WARMTH (injection site swelled up and got very hot) and VACCINATION SITE SWELLING (injection site swelled up) had resolved. At the time of the report, ERYTHEMA (Redness), TENDERNESS (tenderness), VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching), VACCINATION SITE ERYTHEMA (a band of red 2 inches below the injection site), HEADACHE (flash headache), MYALGIA (body aches) and VACCINATION SITE RASH (6 inch patch of rash over the top of my left shoulder and down across the armpit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: 6 inch patch of rash over the top of my left shoulder and down across the armpit with itching; 6 inch patch of rash over the top of my left shoulder and down across the armpit; body aches; flash headache; injection site swelled up and got very hot; injection site swelled up; a band of red 2 inches below the injection site; Redness; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), TENDERNESS (tenderness), VACCINATION SITE WARMTH (injection site swelled up and got very hot), VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching) and VACCINATION SITE SWELLING (injection site swelled up) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included WELLNESS FORMULA for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced ERYTHEMA (Redness) and TENDERNESS (tenderness). On 17-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site swelled up and got very hot), VACCINATION SITE SWELLING (injection site swelled up) and VACCINATION SITE ERYTHEMA (a band of red 2 inches below the injection site). On 26-Feb-2021, the patient experienced HEADACHE (flash headache). On 27-Feb-2021, the patient experienced MYALGIA (body aches). On 04-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching) and VACCINATION SITE RASH (6 inch patch of rash over the top of my left shoulder and down across the armpit). On 21-Feb-2021, VACCINATION SITE WARMTH (injection site swelled up and got very hot) and VACCINATION SITE SWELLING (injection site swelled up) had resolved. At the time of the report, ERYTHEMA (Redness), TENDERNESS (tenderness), VACCINATION SITE PRURITUS (6 inch patch of rash over the top of my left shoulder and down across the armpit with itching), VACCINATION SITE ERYTHEMA (a band of red 2 inches below the injection site), HEADACHE (flash headache), MYALGIA (body aches) and VACCINATION SITE RASH (6 inch patch of rash over the top of my left shoulder and down across the armpit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 years old patient received a dose; A spontaneous report was received from a nurse concerning a 16-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  the event is 16 year old patient received a dose.  The patient's medical history, was not provided by the reporter, included no known allergy and  Concomitant medications were not  reported .   On 09 Mar  2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 048A21A) intramuscularly for prophylaxis of COVID-19 infection.   On 9 Mar 2021 the pharmacist Reported that 16 year old patient has Received his first dose of vaccine. and he want to know the patient can receive his second dose or not.  Action taken with mRNA-1273 in response to the events was not reported.   The out come of the event 16 year old patient received a dose is considered resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273.  There were no reported adverse events associated with this case.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Glucose tolerance test, Pregnancy test, Ultrasound scan
Clinical narrative: 36 weeks pregnant patient got first dose of Moderna COVID-19 vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (36 weeks pregnant patient got first dose of Moderna COVID-19 vaccine) in a 27-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (occasional). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 30-Jun-2020 and the estimated date of delivery was 06-Apr-2021. On 10-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (36 weeks pregnant patient got first dose of Moderna COVID-19 vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-sixth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 10-Mar-2021, EXPOSURE DURING PREGNANCY (36 weeks pregnant patient got first dose of Moderna COVID-19 vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jul-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Glucose tolerance test: normal (normal) Normal. On an unknown date, Ultrasound scan: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was 36 weeks pregnant and in third semester at the time of the report.  The patient had established prenatal care and had one fetus. There was no complications or acute illness during this pregnancy till date. The patient give live birth to full term baby on 28-Aug-2015.  No treatment details were provided by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: a little sore arm; felt very very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little sore arm) and FATIGUE (felt very very tired) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 003A21) for COVID-19 vaccination.     The patient's past medical history included Asthma, Stroke (Two times), Rheumatic fever (when patient was 5 year old) and Diverticulosis. Concomitant products included POTASSIUM and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication, CLOPIDOGREL BISULFATE (PLAVIX).   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (a little sore arm) and FATIGUE (felt very very tired). At the time of the report, PAIN IN EXTREMITY (a little sore arm) and FATIGUE (felt very very tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Action taken with mRNA-123 is not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-060848 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060848:Dose 2
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: During the injection, she felt pain in and around the arm and down to her hand; Lymph nodes swelling in the left breast area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (During the injection, she felt pain in and around the arm and down to her hand) and LYMPHADENOPATHY (Lymph nodes swelling in the left breast area) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (During the injection, she felt pain in and around the arm and down to her hand) and LYMPHADENOPATHY (Lymph nodes swelling in the left breast area). The patient was treated with Manual therapy (ice) for Vaccination site pain. At the time of the report, VACCINATION SITE PAIN (During the injection, she felt pain in and around the arm and down to her hand) and LYMPHADENOPATHY (Lymph nodes swelling in the left breast area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The patient was treated with Manual therapy (ice) for Vaccination site pain.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Injection site pain, Skin swelling
Clinical narrative: (bruise) noticeable puffy; soreness at the site of injection; purple bruise which is just above the wrist - left arm; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (purple bruise which is just above the wrist - left arm), SKIN SWELLING ((bruise) noticeable puffy) and INJECTION SITE PAIN (soreness at the site of injection) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE PAIN (soreness at the site of injection). In March 2021, the patient experienced CONTUSION (purple bruise which is just above the wrist - left arm). On an unknown date, the patient experienced SKIN SWELLING ((bruise) noticeable puffy). On 05-Mar-2021, INJECTION SITE PAIN (soreness at the site of injection) had resolved. At the time of the report, CONTUSION (purple bruise which is just above the wrist - left arm) and SKIN SWELLING ((bruise) noticeable puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral, Tongue discomfort, Tongue pruritus
Clinical narrative: like itching and tingling and a little heat; like itching and tingling and a little heat; like itching and tingling and a little heat; lips feel half asleep, little sensitivity, like coming off the effect of the dentist's anesthesia; numbness on the right side of the tongue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Mar-2021 and was forwarded to Moderna on 10-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (numbness on the right side of the tongue), TONGUE PRURITUS (like itching and tingling and a little heat), PARAESTHESIA ORAL (like itching and tingling and a little heat), TONGUE DISCOMFORT (like itching and tingling and a little heat) and HYPOAESTHESIA ORAL (lips feel half asleep, little sensitivity, like coming off the effect of the dentist's anesthesia) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 immunisation.     No Medical History information was reported.   On 04-Mar-2021 at 3:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (numbness on the right side of the tongue). On an unknown date, the patient experienced TONGUE PRURITUS (like itching and tingling and a little heat), PARAESTHESIA ORAL (like itching and tingling and a little heat), TONGUE DISCOMFORT (like itching and tingling and a little heat) and HYPOAESTHESIA ORAL (lips feel half asleep, little sensitivity, like coming off the effect of the dentist's anesthesia). At the time of the report, HYPOAESTHESIA ORAL (numbness on the right side of the tongue), TONGUE PRURITUS (like itching and tingling and a little heat), PARAESTHESIA ORAL (like itching and tingling and a little heat), TONGUE DISCOMFORT (like itching and tingling and a little heat) and HYPOAESTHESIA ORAL (lips feel half asleep, little sensitivity, like coming off the effect of the dentist's anesthesia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. No treatment information was provided.     Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow up received on 05-MAY-2021 and it contains No new information( patient denied further follow up)
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Feeding disorder, Gait disturbance, Speech disorder, Tremor
Clinical narrative: Couldn't walk; Couldn't feed herself; Couldn't talk; Disoriented; Shaking; This spontaneous case was reported by a patient and describes the occurrence of GAIT DISTURBANCE (Couldn't walk), FEEDING DISORDER (Couldn't feed herself), SPEECH DISORDER (Couldn't talk), DISORIENTATION (Disoriented) and TREMOR (Shaking) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025AZ1A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 pneumonia (hospitalized) in December 2020.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced GAIT DISTURBANCE (Couldn't walk), FEEDING DISORDER (Couldn't feed herself), SPEECH DISORDER (Couldn't talk), DISORIENTATION (Disoriented) and TREMOR (Shaking). At the time of the report, GAIT DISTURBANCE (Couldn't walk), FEEDING DISORDER (Couldn't feed herself), SPEECH DISORDER (Couldn't talk), DISORIENTATION (Disoriented) and TREMOR (Shaking) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: swelling in injection site; pain in injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (swelling in injection site) and VACCINATION SITE PAIN (pain in injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swelling in injection site) and VACCINATION SITE PAIN (pain in injection site). At the time of the report, VACCINATION SITE SWELLING (swelling in injection site) and VACCINATION SITE PAIN (pain in injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: Symptoms of covid and Caught COVID after first dose and tested positive; Congestion; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Symptoms of covid and Caught COVID after first dose and tested positive) and NASAL CONGESTION (Congestion) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced COVID-19 (Symptoms of covid and Caught COVID after first dose and tested positive) and NASAL CONGESTION (Congestion). At the time of the report, COVID-19 (Symptoms of covid and Caught COVID after first dose and tested positive) and NASAL CONGESTION (Congestion) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: redness on the arm; little itchy on the arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on the arm) and PRURITUS (little itchy on the arm) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced ERYTHEMA (redness on the arm) and PRURITUS (little itchy on the arm). At the time of the report, ERYTHEMA (redness on the arm) and PRURITUS (little itchy on the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Diarrhoea, Dysphonia, Fatigue, Pain in extremity
Clinical narrative: slight jabbing pain on her left side; experiencing seasonal allergies; getting hoarse; a jabbing left side chest pain; diarrhea; felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (a jabbing left side chest pain), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies) and DYSPHONIA (getting hoarse) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Sulfonamide allergy, Drug allergy (codeine) and Seasonal allergy. Concomitant products included ATENOLOL, LOSARTAN, AMLODIPINE, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC) for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FATIGUE (felt a little tired). On 09-Mar-2021, the patient experienced CHEST PAIN (a jabbing left side chest pain) and DIARRHOEA (diarrhea). On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies) and DYSPHONIA (getting hoarse). At the time of the report, CHEST PAIN (a jabbing left side chest pain), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies), DYSPHONIA (getting hoarse) and FATIGUE (felt a little tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Event outcome updated.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Seasonal allergy
Clinical narrative: slight jabbing pain on her left side; experiencing seasonal allergies; getting hoarse; a jabbing left side chest pain; diarrhea; felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (a jabbing left side chest pain), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies) and DYSPHONIA (getting hoarse) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Sulfonamide allergy, Drug allergy (codeine) and Seasonal allergy. Concomitant products included ATENOLOL, LOSARTAN, AMLODIPINE, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC) for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FATIGUE (felt a little tired). On 09-Mar-2021, the patient experienced CHEST PAIN (a jabbing left side chest pain) and DIARRHOEA (diarrhea). On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies) and DYSPHONIA (getting hoarse). At the time of the report, CHEST PAIN (a jabbing left side chest pain), DIARRHOEA (diarrhea), PAIN IN EXTREMITY (slight jabbing pain on her left side), SEASONAL ALLERGY (experiencing seasonal allergies), DYSPHONIA (getting hoarse) and FATIGUE (felt a little tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Event outcome updated.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Pain
Clinical narrative: Very little breathing; Pain; Headache; Extreme tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Very little breathing), PAIN (Pain), HEADACHE (Headache) and FATIGUE (Extreme tiredness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DYSPNOEA (Very little breathing), PAIN (Pain), HEADACHE (Headache) and FATIGUE (Extreme tiredness). At the time of the report, DYSPNOEA (Very little breathing), PAIN (Pain), HEADACHE (Headache) and FATIGUE (Extreme tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills). At the time of the report, CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Vaccination site reaction
Clinical narrative: COVID arm; COVID arm itchier; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm) and INJECTION SITE PRURITUS (COVID arm itchier) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE REACTION (COVID arm) and INJECTION SITE PRURITUS (COVID arm itchier). At the time of the report, VACCINATION SITE REACTION (COVID arm) had not resolved and INJECTION SITE PRURITUS (COVID arm itchier) outcome was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: knot at the site of injection.; Red knot at the site of injection; Itchy knot at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (knot at the site of injection.), VACCINATION SITE ERYTHEMA (Red knot at the site of injection) and VACCINATION SITE PRURITUS (Itchy knot at the site of injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE MASS (knot at the site of injection.), VACCINATION SITE ERYTHEMA (Red knot at the site of injection) and VACCINATION SITE PRURITUS (Itchy knot at the site of injection). At the time of the report, VACCINATION SITE MASS (knot at the site of injection.), VACCINATION SITE ERYTHEMA (Red knot at the site of injection) and VACCINATION SITE PRURITUS (Itchy knot at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Dizziness, Fatigue
Clinical narrative: dizziness; arm immobility/ inability to use arm; weakness in limbs; lack of appetite/ unable to eat or drink; lethargy; fever; nausea; fatigue; chills; soreness at injection site/ tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink) and LETHARGY (lethargy) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 09-Mar-2021 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021 at 2:00 AM, the patient experienced DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink), LETHARGY (lethargy), NAUSEA (nausea), FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (soreness at injection site/ tenderness at injection site). 10-Mar-2021 at 2:00 AM, the patient experienced PYREXIA (fever). At the time of the report, DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink), LETHARGY (lethargy), PYREXIA (fever), NAUSEA (nausea), FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (soreness at injection site/ tenderness at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 100 to 101 degree f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Mobility decreased, Muscular weakness, Nausea, Pyrexia
Clinical narrative: dizziness; arm immobility/ inability to use arm; weakness in limbs; lack of appetite/ unable to eat or drink; lethargy; fever; nausea; fatigue; chills; soreness at injection site/ tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink) and LETHARGY (lethargy) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 09-Mar-2021 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021 at 2:00 AM, the patient experienced DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink), LETHARGY (lethargy), NAUSEA (nausea), FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (soreness at injection site/ tenderness at injection site). 10-Mar-2021 at 2:00 AM, the patient experienced PYREXIA (fever). At the time of the report, DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink), LETHARGY (lethargy), PYREXIA (fever), NAUSEA (nausea), FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (soreness at injection site/ tenderness at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 100 to 101 degree f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: dizziness; arm immobility/ inability to use arm; weakness in limbs; lack of appetite/ unable to eat or drink; lethargy; fever; nausea; fatigue; chills; soreness at injection site/ tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink) and LETHARGY (lethargy) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 09-Mar-2021 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021 at 2:00 AM, the patient experienced DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink), LETHARGY (lethargy), NAUSEA (nausea), FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (soreness at injection site/ tenderness at injection site). 10-Mar-2021 at 2:00 AM, the patient experienced PYREXIA (fever). At the time of the report, DIZZINESS (dizziness), MOBILITY DECREASED (arm immobility/ inability to use arm), MUSCULAR WEAKNESS (weakness in limbs), DECREASED APPETITE (lack of appetite/ unable to eat or drink), LETHARGY (lethargy), PYREXIA (fever), NAUSEA (nausea), FATIGUE (fatigue), CHILLS (chills) and VACCINATION SITE PAIN (soreness at injection site/ tenderness at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 100 to 101 degree f High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: Blistering on back; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of BLISTER (Blistering on back) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLISTER (Blistering on back). At the time of the report, BLISTER (Blistering on back) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Vaccination site pain
Clinical narrative: can't barely walk; her ankles hurting really bad; a little bit of soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (can't barely walk), VACCINATION SITE PAIN (a little bit of soreness in her arm) and ARTHRALGIA (her ankles hurting really bad) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (a little bit of soreness in her arm). On 10-Mar-2021, the patient experienced GAIT DISTURBANCE (can't barely walk) and ARTHRALGIA (her ankles hurting really bad). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, GAIT DISTURBANCE (can't barely walk), VACCINATION SITE PAIN (a little bit of soreness in her arm) and ARTHRALGIA (her ankles hurting really bad) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Could not sleep; Sore Injection Site/ burning Injection Site; Red to Pink Injection Site size of an egg; Itching Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep), VACCINATION SITE PAIN (Sore Injection Site/ burning Injection Site), VACCINATION SITE ERYTHEMA (Red to Pink Injection Site size of an egg) and VACCINATION SITE PRURITUS (Itching Injection Site) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced INSOMNIA (Could not sleep), VACCINATION SITE PAIN (Sore Injection Site/ burning Injection Site), VACCINATION SITE ERYTHEMA (Red to Pink Injection Site size of an egg) and VACCINATION SITE PRURITUS (Itching Injection Site). On 10-Mar-2021, VACCINATION SITE PAIN (Sore Injection Site/ burning Injection Site) had resolved. At the time of the report, INSOMNIA (Could not sleep), VACCINATION SITE ERYTHEMA (Red to Pink Injection Site size of an egg) and VACCINATION SITE PRURITUS (Itching Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Headache, Hypertension
Clinical narrative: nose started bleeding; high blood pressure; pounding headache; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose started bleeding), HYPERTENSION (high blood pressure) and HEADACHE (pounding headache) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (Had two liver surgeries). Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced EPISTAXIS (nose started bleeding), HYPERTENSION (high blood pressure) and HEADACHE (pounding headache). At the time of the report, EPISTAXIS (nose started bleeding), HYPERTENSION (high blood pressure) and HEADACHE (pounding headache) outcome was unknown.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Maternal exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) in a 42-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use from July 2020 to August 2020. Concomitant products included LEVOTHYROXINE for Hypothyroidism, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 03-Aug-2020 and the estimated date of delivery was 17-May-2021. On 09-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy.  On 09-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Sep-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Blood glucose: normal (normal) Normal. On an unknown date, Ultrasound foetal: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 7-SEP-2020, the patient received a positive pregnancy test. 24-AUG-2020 was reported as estimated date of conception. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Mar-2021: Upon internal review on 19-Jul-2021, patient tab, event- coding, analysis tabs and regulatory reports were updated.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Lip swelling, Swelling face, Swelling of eyelid
Clinical narrative: lip swelling; eye lid swelling; she couldn't wake up from bed, she couldn't move her feet; Face swelling,; Can't pick up feet; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of SWELLING FACE (Face swelling,), GAIT DISTURBANCE (Can't pick up feet), LIP SWELLING (lip swelling), SWELLING OF EYELID (eye lid swelling) and FATIGUE (she couldn't wake up from bed, she couldn't move her feet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPTOR [ATORVASTATIN CALCIUM]) and HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HYDROCHLOROTHIAZIDE) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced SWELLING FACE (Face swelling,) and GAIT DISTURBANCE (Can't pick up feet). On an unknown date, the patient experienced LIP SWELLING (lip swelling), SWELLING OF EYELID (eye lid swelling) and FATIGUE (she couldn't wake up from bed, she couldn't move her feet). At the time of the report, SWELLING FACE (Face swelling,), GAIT DISTURBANCE (Can't pick up feet), LIP SWELLING (lip swelling), SWELLING OF EYELID (eye lid swelling) and FATIGUE (she couldn't wake up from bed, she couldn't move her feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: Gout; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Gout) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced GOUT (Gout). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, GOUT (Gout) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.